Confluence Investment Management LLC Has $140.44 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Confluence Investment Management LLC lowered its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,352,874 shares of the company's stock after selling 26,083 shares during the quarter. Colgate-Palmolive accounts for about 1.9% of Confluence Investment Management LLC's portfolio, making the stock its 15th biggest position. Confluence Investment Management LLC owned about 0.17% of Colgate-Palmolive worth $140,442,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive in the second quarter valued at about $25,000. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after acquiring an additional 125 shares during the last quarter. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Gradient Investments LLC grew its stake in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after acquiring an additional 400 shares in the last quarter. Finally, Financial Connections Group Inc. acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $68,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

CL traded up $1.82 during trading on Friday, hitting $92.59. The stock had a trading volume of 4,567,864 shares, compared to its average volume of 4,378,513. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a 50 day moving average price of $100.91 and a 200-day moving average price of $98.37. Colgate-Palmolive has a one year low of $74.67 and a one year high of $109.30. The firm has a market cap of $75.65 billion, a price-to-earnings ratio of 26.53, a P/E/G ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.16%. Colgate-Palmolive's payout ratio is presently 57.31%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CL shares. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Wednesday. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Finally, Evercore ISI upped their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an "outperform" rating in a research note on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.